Phone: (212) 746-5788
Fax: (212) 746-0975
March 12, 2010 4:53 pm
IPOs Priced Thsi Week - New York Times
Google News - renal cell carcinoma
IPOs Priced Thsi Week New York Times based biotech which is developing a renal cell carcinoma drug similar to blockbuster Avastin, priced 9 million shares at $9 each on Mar. 11. ... Biotechs Continue IPO March, Without Banging The Drums |
|